24_10_STREAM_SiteHeader_OP

RECENT WEBINARS

51:52 Breaking the Titer Ceiling Smarter Media Design for Higher Productivity

Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity

40:25 Automating Cell Therapy Manufacturing Without Redesigning Workflows

Automating Cell Therapy Manufacturing Without Redesigning Workflows

1:05:01 Smarter DNA, Healthier Cells: Circular Single‑Stranded DNA in Gene Editing

Smarter DNA, Healthier Cells

26:13 Creative Chromatography Solutions For Complex Small Molecules

Creative Chromatography Solutions For Complex Small Molecules

24:07 Solving Formulation Challenges Across Modalities: Patient-Centric Nanoparticle Approaches for Small and Large Molecules

Solving Formulation Challenges Across Modalities

40:57 Viral Safety Testing In Biologics: Detecting What Current Methods Miss

Viral Safety Testing In Biologics: Detecting What Current Methods Miss

51:32 lonza cracking complexity

Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs

56:14 lonza clones

Faster Clones, Simpler Process: What's Changing In CHO Expression?

30:03 Hidden In Plain Sight: How Solid-State Science Solves Your Toughest API Challenges

How Solid-State Science Solves Your Toughest API Challenges

1:01:23 west tech transfer

From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System

1:01:19 Advancing Next Gen Antibodies And ADCs: From AI Driven Cell Line Development To Integrated Manufacturing Bucket

Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing

More Recent Webinars

SMALL MOLECULE OUTSOURCING

31:11 GettyImages-1322996506 Capital Equipment In Lab

CESS Technology

2:02 GettyImages-950086574-oral-solid-OSD-pill-tablet-capsule-development

Small Molecule APIs: From Pre-RSM To Final API

4:20 Adare-Feature

Developing Long-Acting Contraceptive Injectables

3:32 Collaboration Across Cambrex

Fostering A Collaborative, Cross-Functional Approach

16:26 Expanding The OSD Toolbox

Expanding The OSD Toolbox

45:22 1_42C78B445EC0AB6C66A5ABE8052C828B

Local Delivery For Treatment Of Lung Cancer

53:07 01 West

Combination Products: Navigating Regulatory Strategy, Design Verification

5:04 Adare Pessano Tour

Integration From Formulation Development To Manufacturing, Packaging

1:02:40 iStock-943878650-packaging-tablet-capsule

Future Of Pharma Packaging: Trends, Tech, And Patient Solutions

3:27 Collaboration With Clients

Collaboration With Clients

4:02 Luigi Bellone

Cambrex Scientist Spotlight: Luigi Bellone

50:18 West-SBO 1 - GC_APP_3e FunShot_4

A Data-Driven Approach To Container Closure Integrity

More Small Molecule Outsourcing Videos

CELL AND GENE OUTSOURCING

1:53 Andelyn

Manufacturing Life-Saving Gene Therapies

20:09 MilliporeSigma 1

Smart Bioprocess Data Utilization For Advanced Analytics And Monitoring With Data Analytics Tools Purpose-Built For Bioprocessing

57:12 Effective Supply Chain And QC Testing Through Collaborative Partnerships

Effective Supply Chain And QC Testing Through Collaborative Partnerships

52:14 GettyImages-597971944-viral-vector-AAV-adeno-associated-virus

Pioneering Solutions That Turn Hope Into Reality

48:51 Lipid Nanoparticle mRNA Vaccine GettyImages-1418152448

An Early Formulation Screening Service

3:46 Scientists Viewing Tablet GettyImages-1370154332

Meet The Experts: Part 3 - Chemometrics And Model Building

58:28 GettyImages-155372946-cold-chain-cryopreservation-logistics

Cryopreservation Best Practices For Cell & Gene Therapy Source Material

50:05 West

Selecting Containers For Sensitive And Costly Cell & Gene Therapies

40:52 Scientists In Laboratory GettyImages-1140779754

A Rapid, Innovative Approach To Release Testing

33:26 Purity as a priority

Purity As A Priority: Optimizing Safety Measures For rAAV Therapies

58:56 GettyImages-1214111376 scientists computer

Optimization-By-Design — A Critical Factor In Viral Vector Scale Up

5:22 Combining Expertise With Best-In-Class Technology

Combining Expertise With Best-In-Class Technology

More Cell and Gene Outsourcing Videos

OUTSOURCED PHARMA CAPACITY UPDATE

16:29 Resilience Capabilities Update May 2026 Large Molecule

Resilience Capabilities Update May 2026: Large Molecule

14:20 Rentschler Biopharma Capabilities Update May 2026 Large Molecule

Rentschler Biopharma Capabilities Update May 2026: Large Molecule

18:31 samsung expanding global capacity

Samsung Biologics Capabilities Update May 2026: Large Molecule

16:44 rezon bio integrated biologics

Rezon Bio Capabilities Update May 2026: Large Molecule

14:34 Alcami Beyond Capacity

Alcami Capabilities Update May 2026: Large Molecule

17:53 Simtra Capabilities Update April 2026: Fill/Finish

Simtra Capabilities Update April 2026: Fill/Finish

20:40 Upperton OPCU

Upperton Capabilities Update April 2026: Fill/Finish

19:01 Upperton Pharma Solutions Capabilities Update April 2026 Small Molecule Drug Product

Upperton Pharma Solutions Capabilities Update April 2026: Small Molecule Drug Product

16:10 Thermo Fisher Scientific Capabilities Update April 2026 Small Molecule Drug Product

Thermo Fisher Scientific Capabilities Update April 2026: Small Molecule Drug Product

15:28 Douglas CDMO Capabilities Update April 2026 Small Molecule Drug Product

Douglas CDMO Capabilities Update April 2026: Small Molecule Drug Product

20:38 Bora Pharmaceuticals Capabilities Update April 2026 Small Molecule Drug Product

Bora Pharmaceuticals Capabilities Update April 2026: Small Molecule Drug Product

15:48 Kindeva Capabilities Update April 2026: Fill/ Finish

Kindeva Capabilities Update April 2026: Fill/ Finish

Outsourced Pharma Capacity Update Page

BIOLOGIC OUTSOURCING

5:27 AGC Bio Seattle Site Tour

Step Inside One Of America's Leading Protein Biologics CDMO Sites

4:53 MAST Autosampling Solution

Introducing The MAST® Autosampling Solution

1:48 Microbial Expertise That Scales Globally

Microbial Expertise That Scales Globally

18:02 BIO-EXPO Live

Millipore Sigma Bio-Expo Live June 2025: Downstream Bioprocessing

16:14 BIO-EXPO

High Capacity, Scalable Cation Exchange Chromatography Membrane For Purification Of Monoclonal Antibody

3:46 Scientists Viewing Tablet GettyImages-1370154332

Meet The Experts: Part 3 - Chemometrics And Model Building

2:07 AGC Bio 2024 CEO Sizzle

A Friendly CDMO Expert: New CEO Outlines AGC Bio's Transformation

3:26 Milliporesigma

ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients

1:44 Mastering mRNA Manufacturing

Master Your mRNA Manufacturing

5:22 Combining Expertise With Best-In-Class Technology

Combining Expertise With Best-In-Class Technology

1:00 60-Seconds of Science: Optimizing Complex Molecule Production

60-Seconds Of Science: Optimizing Complex Molecule Production

More Biologic Outsourcing Videos

OUTSOURCED PHARMA LIVE

4:33 Match The CDMO To The Stage Of Development

Match The CDMO To The Stage Of Development

2:59 Are You Really Ready To Transfer?

Are You Really Ready To Transfer?

4:22 The Data Package Blind Spots That Create Surprises

The Data Package Blind Spots That Create Surprises

4:03 Tech Transfer Is Not A Handoff

Tech Transfer Is Not A Handoff

0:58 Tech Transfer Is More Than A Batch Record

Tech Transfer Is More Than A Batch Record

56:08 Beyond Data Packages: Derisking Tech Transfer To CDMOs

Beyond Data Packages: Derisking Tech Transfer To CDMOs

2:08 ADC Outsourcing Is Now A Global Strategy

ADC Outsourcing Is Now A Global Strategy

2:36 Where Sponsors Underestimate ADC Complexity

Where Sponsors Underestimate ADC Complexity

57:30 ADC Outsourcing: Plan Smart Now or Suffer Later

ADC Outsourcing: Plan Smart Now Or Suffer Later

1:57 Keep The Science In-House, Externalize The Hands

Keep The Science In-House, Externalize The Hands

2:41 Linker-Payload Risk Is Where The Bar Is Rising

Linker-Payload Risk Is Where The Bar Is Rising

8:15 Navigating Geopolitical Risk Without Overcorrecting

Navigating Geopolitical Risk Without Overcorrecting

Outsourced Pharma Live Page

OUTSOURCING FUNDAMENTALS

1:13 23_10_OPL_Challenges_Webinar_Seg01

Workforce Challenges Key To Outsourcing

1:01:52 Selecting a cdmo

Selecting A CDMO: A Guide To Successful Collaboration

0:30 GettyImages-1146473276-team-collaboration-partnership-discussion

Fostering CDMO Collaboration On Both Sides

0:31 How Are We Responding To Provide Confidence For Customers

Annex 1 FAQs: How Are We Responding To Provide Confidence For Customers?

0:23 Establishing A Container Closure System

Establishing A Container Closure System

0:25 What Was The Biggest Challenge With EU GMP Annex 1

Annex 1 FAQs: What Was The Biggest Challenge With EU GMP Annex 1?

0:25 Accountability For The Whole PFS System

Accountability For The Whole PFS System

0:44 How Is Behavior Changing As A Result Of EU GMP Annex 1

Annex 1 FAQs: How Is Behavior Changing As A Result Of EU GMP Annex 1?

0:23 Planning For Scale-Up

Planning For Scale-Up

0:29 Why Is A Good Supplier Partnership Pivotal To Meet Regulatory Expectations

Annex 1 FAQs: Why Is A Good Supplier Partnership Pivotal To Meet Regulatory Expectations?

0:30 Scientist in lab GettyImages-872025342

Collaborating To Craft Efficient Processes

2:30 West-Feature-PFS SYRG-0178 NovaPure

Consistent, Reliable, High-Quality Components

4:15 23_10_OPL_Challenges_Webinar_Seg02

Managing Multiple Partners – And Materials – From Around The Globe

0:23 Minimizing Particulate Risk

Minimizing Particulate Risk

0:22 Start Packaging Development Early

Start Packaging Development Early

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

0:20 Streamline Your Path To Clinical Fill

Streamline Your Path To Clinical Fill

1:28 Start With An Integrated, Verified PFS System

Start With An Integrated, Verified PFS System

0:26 Efficient, Single-Source PFS Supply

Efficient, Single-Source PFS Supply

0:44 How Is West Responding To Foster Trust With Its Customers

Annex 1 FAQs: How Are We Responding To Foster Trust With Customers?

0:24 Protecting Your Drug Product

Protecting Your Drug Product

0:29 How Did West Respond To The EU GMP Annex 1 Revision

Annex 1 FAQs: Responding To The 2022 Revision

0:59 How Does West Understand Risk Regarding Contamination Control

Annex 1 FAQs: How Do You Understand Risk Regarding Contamination Control?

0:30 GettyImages-1413600685-lab-team-collaboration-computer-research

Visionary Thinkers And Problem Solvers: The Cambrex Team

1:27 Redefining Prefillable Syringe System

Redefining Prefillable Syringe System

More Outsourcing Fundamentals Videos

BUSINESS OF BIOTECH

48:37 Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.

Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.

55:16 Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho

Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho

55:21 Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.

Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.

1:24:20 The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

49:55 Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.

Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D.

55:26 Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane

Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane

50:58 Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.

Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D.

54:15 Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.

Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D.

55:59 From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.

From Partnered ASO Therapies To A Wholly-Owned Pipeline With Ionis's Brett Monia, Ph.D.

47:40 Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary

Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary

46:56 The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

58:36 Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

40:29 Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

55:44 Investing In Early-Stage Oncology With Yosemite's Dan McHugh

Investing In Early-Stage Oncology With Yosemite's Dan McHugh

51:00 Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

54:03 Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

48:33 Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

54:00 Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

58:19 An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

56:56 Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

42:39 Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

44:38 BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

56:00 BoB@JPM: Ron Cooper, enGene

BoB@JPM: Ron Cooper, enGene

36:08 BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

58:44 A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith

A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith

1:21:11 Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead

46:43 Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

55:39 Modernizing Clinical Trial Operations With Merck's Jennifer Sheller

Modernizing Clinical Trial Operations With Merck's Jennifer Sheller

55:39 Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.

53:54 Engineering B Cells With Immusoft's Sean Ainsworth

Engineering B Cells With Immusoft's Sean Ainsworth

51:32 Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

58:44 Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

57:04 BoB_1280x720_Allan_Shaw

Biotech Funding And IPO Temperature Check With CREATE Medicine's Allan Shaw

46:14 Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

42:51 Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

31:47 BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

33:34 BoB In South Florida: Anthony Japour, M.D., iTolerance

BoB In South Florida: Anthony Japour, M.D., iTolerance

33:08 BoB In South Florida: Daniel Teper, NAYA Therapeutics

BoB In South Florida: Daniel Teper, NAYA Therapeutics

34:58 BoB In South Florida: Raquel Cabo, Miami Biotech Collective

BoB In South Florida: Raquel Cabo, Miami Biotech Collective

57:58 The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

57:27 Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

58:25 Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

57:54 Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

1:04:36 Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

52:07 BoB_1280x720_Vladimir_Cmiljanovic

Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.

52:37 Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

58:11 How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

52:03 The Generalist Biotech CEO With Seekyo's Oury Chetboun

The Generalist Biotech CEO With Seekyo's Oury Chetboun

54:07 BoB_1280x720_Ebrahim_Delpassand

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

45:41 BoB_1280x720_Ep263

Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.

54:23 24_01_BoB_1280x720_Ep262

The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics

32:40 24_01_BoB_1280x720_Ep261

BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

56:34 24_01_BoB_1280x720_Ep260

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

1:04:33 24_01_BoB_1280x720_Ep259

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

58:23 24_01_BoB_1280x720_Ep258_2

Proactive Procurement Strategies For Biotech With Tom Wells

1:06:27 24_01_BoB_1280x720_Ep257

The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson

55:50 24_01_BoB_1280x720_Ep256

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.

56:27 24_01_BoB_1280x720_Ep255

Biotech Angel Investing With Yaniv Sneor

59:23 24_01_BoB_1280x720_Ep254

Leading A tRNA Startup With Alltrna's Michelle Werner

39:45 24_01_BoB_1280x720_Ep253

Executing A Product Pivot With Vir's Mark Eisner, MD

55:54 24_01_BoB_1280x720_Ep252

Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

55:45 24_01_BoB_1280x720_Ep251

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

46:08 24_01_BoB_1280x720_Ep250

The Implications Of China's Growing Biotech Industry With Allan Shaw

44:20 24_01_BoB_1280x720_Ep249

How To Be A CFO With Insmed's Sara Bonstein

46:43 24_01_BoB_1280x720_Ep248

Deal And Investment Trends With Investment Banker David Sans

34:44 24_01_BoB_1280x720_Ep247

Business of Biotech 2.0 with Ben Comer

43:32 24_01_BoB_1280x720_Ep246

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

43:46 24_01_BoB_1280x720_Ep245

BoB@JPM: Kasper Roet, Ph.D., QurAlis

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

37:00 24_01_BoB_1280x720_Ep241

BoB@JPM: Ran Zheng, Landmark Bio

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

43:00 24_01_BoB_1280x720_Ep239

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

47:50 24_01_BoB_1280x720_Ep238

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

1:13:36 24_01_BoB_1280x720_Ep237

High-Throughput Discovery With BIOPTIC's Andrey Dobry

1:06:32 24_01_BoB_1280x720_Ep236

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

54:04 24_01_BoB_1280x720_Ep235

Biotech Story Time With Tal Zaks, M.D. (Part 2)

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

55:25 24_01_BoB_1280x720_Ep233

Biotech Story Time With Tal Zaks, M.D. (Part 1)

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

1:03:50 24_01_BoB_1280x720_Ep231

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

45:26 24_01_BoB_1280x720_Ep230

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

49:54 24_01_BoB_1280x720_Ep229

Biopolitics With Allan Shaw

1:01:35 24_01_BoB_1280x720_Ep228

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

46:48 24_01_BoB_1280x720_Ep227

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

49:12 24_01_BoB_1280x720_Ep226

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

44:14 24_01_BoB_1280x720_Ep225

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

51:34 24_01_BoB_1280x720_Ep223

Biotech C-Suite Construction With Allan Shaw

59:19 24_01_BoB_1280x720_Ep222

The Peptide Promise With NervGen's Mike Kelly

1:17:16 24_01_BoB_1280x720_Ep221

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

1:14:26 24_01_BoB_1280x720_Ep220

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

1:04:47 24_01_BoB_1280x720_Ep217

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

1:03:07 24_01_BoB_1280x720_Ep216

mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

59:37 24_01_BoB_1280x720_Ep214

Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

56:38 24_01_BoB_1280x720_Ep212

Expanding The Proteome with ProFound's John Lepore, M.D.

1:06:39 24_01_BoB_1280x720_Ep211

From The Bench To The Boardroom with ImmunityBio's Enrique Diloné

Business of Biotech Page

CELL & GENE PODCAST

23:00 Exploring Dendritic Cell Therapy for Solid Tumors with Diakonos Oncology's Jay Hartenbach

Exploring Dendritic Cell Therapy for Solid Tumors with Diakonos Oncology's Jay Hartenbach

1:25:50 Cell & Gene: The Podcast Presents: Better Biopharma’s Editors’ Roundtable — A Midyear Look at the 2026 Life Sciences Industry

Cell & Gene: The Podcast Presents: Better Biopharma's Editors' Roundtable — A Midyear Look at the 2026 Life Sciences Industry

18:14 Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers

Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers

18:14 Reimagining In Vivo Gene Editing Through Base Editing and Targeted Delivery with Beam Therapeutics' Gopi Shanker, Ph.D.

Reimagining In Vivo Gene Editing Through Base Editing and Targeted Delivery with Beam Therapeutics' Gopi Shanker, Ph.D.

22:33 Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics' Dr. Naji Gehchan

Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics' Dr. Naji Gehchan

31:46 The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.

The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.

18:16 Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts

Redefining CAR-T Timing and Patient Access with Allogene Therapeutics' Dr. Zachary Roberts

43:45 Building Integrated cGMP Systems for Autologous Cell Therapies with MassGen's Tatyana Matveeva, Ph.D.

Building Integrated cGMP Systems for Autologous Cell Therapies with MassGen's Tatyana Matveeva, Ph.D.

23:30 Rewriting Disease Biology Through LSD1 Inhibition with Oryzon's Carlos Buesa, Ph.D.

Rewriting Disease Biology Through LSD1 Inhibition with Oryzon's Carlos Buesa, Ph.D.

20:49 Advancing Early Detection in Rare Cancers with Catriona Jamieson, M.D., Ph.D.

Advancing Early Detection in Rare Cancers with Catriona Jamieson, M.D., Ph.D.

27:20 Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka

Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka

28:04 Scaling CRISPR for Rare Disease with Aurora Therapeutics' Dr. Edward Kaye

Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye

More Cell & Gene Podcast Videos

MOST RECENT OUTSOURCED PHARMA LIVE VIDEO

4:33 Match The CDMO To The Stage Of Development
Match The CDMO To The Stage Of Development

This segment of the Outsourced Pharma Live event, “Beyond Data Packages: De-Risking Tech Transfer To CDMOs,” explores why sponsors need to be clear about what they actually need from a CDMO at each stage of development.